Form 4: Veracyte Officer's Tax Withholding on RSU Vesting

Veracyte's VP, Chief Accounting Officer, Jonathan Wygant, had 3,006 shares withheld for tax obligations related to restricted stock unit vesting on March 2, 2026.

Summary

• Jonathan Wygant, VP, Chief Accounting Officer of Veracyte, Inc. (VCYT), reported a transaction on March 2, 2026.
• The transaction involved the disposition of 3,006 shares of common stock at a price of $36.01 per share.
• This disposition represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units (RSUs) and is not a sale.
• Following this transaction, Jonathan Wygant beneficially owns 34,909 shares of Veracyte common stock.
• The reported beneficial ownership includes 495 shares of common stock purchased on January 31, 2026, through the Veracyte, Inc. Employee Stock Purchase Plan (ESPP).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive event. While shares were disposed of, it was for tax obligations related to RSU vesting, which is a form of compensation. The additional purchase via ESPP further indicates insider confidence.

Positives

• The underlying event for the share disposition was the vesting of restricted stock units, indicating compensation for the reporting person.
• Jonathan Wygant also purchased 495 shares through the Employee Stock Purchase Plan, demonstrating continued investment in the company.

Negatives

• A total of 3,006 shares of common stock were withheld to cover tax obligations, reducing the direct beneficial ownership of the reporting person.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transaction reports like Form 4 provide transparency into executive compensation and ownership changes. While this specific filing details a routine tax withholding event, it is part of the broader landscape of executive compensation practices within the biotechnology and diagnostics industry, where equity-based incentives are common.

Comparison to Industry Standards

• Insider transactions, particularly those related to tax withholdings on RSU vesting, are standard compensation practices across most publicly traded companies, including those in the biotechnology sector.
• The use of Employee Stock Purchase Plans (ESPPs) is also a common benefit offered by companies like Veracyte to encourage employee ownership, aligning employee interests with shareholder value.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding an executive's equity compensation and ownership, which is a standard part of corporate governance.
• Employees: The RSU vesting and ESPP participation highlight the company's equity compensation programs, which can be a positive for employee retention and motivation.

Key Dates

Keywords

Veracyte, VCYT, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Employee Stock Purchase Plan, ESPP, Jonathan Wygant